NOVA PHARMACEUTICALS — Paracetamol Importer Profile
Pharmaceutical Importer · #12 buyer for Paracetamol · $11.4M import value · 553 shipments · AUSTRALIA · DGFT Verified
NOVA PHARMACEUTICALS is the #12 importer of Paracetamol from India with $11.4M in import value and 553 verified shipments. NOVA PHARMACEUTICALS holds a 0.9% market share in Paracetamol imports based in AUSTRALIA. The company sources from 3 verified suppliers across 314 formulations shipped to 3 countries.
NOVA PHARMACEUTICALS — Paracetamol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Paracetamol to NOVA PHARMACEUTICALS?
Verified from 553 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MARKSANS PHARMA LIMITED | $4.6M | 257 | 40.3% |
| V S INTERNATIONAL PRIVATE LIMITED | $4.1M | 193 | 35.8% |
| ADCOCK INGRAM LIMITED | $2.7M | 103 | 23.9% |
NOVA PHARMACEUTICALS sources Paracetamol from 3 verified Indian suppliers based on 553 customs records. The primary supplier is MARKSANS PHARMA LIMITED accounting for 40.3% of imports.
How Does NOVA PHARMACEUTICALS Compare to Nearest Paracetamol Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | BELLS HEALTHCARE | UNITED KINGDOM | $3.4M | 80 | $42.1K |
| 11 | CICI SARL | MALI | $3.3M | 111 | $29.8K |
| 12 | NOVA PHARMACEUTICALS ★ | AUSTRALIA | $3.1M | 84 | $36.5K |
| 13 | PERRIGO | UNITED KINGDOM | $3.1M | 121 | $25.2K |
| 6 | SMITHKLINE BEECHAM PVT LTD | SRI LANKA | $2.8M | 55 | $50.0K |
NOVA PHARMACEUTICALS ranks #12 among 2,197 Paracetamol importers from India. Average shipment value of $36.5K compared to the market average of $32.6K. The closest competitors by value are BELLS HEALTHCARE and CICI SARL.
Where Does NOVA PHARMACEUTICALS Import Paracetamol To?
Destination countries from 553 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $9.2M | 475 | 80.8% |
| SOUTH AFRICA | $1.2M | 38 | 10.4% |
| SINGAPORE | $996.0K | 40 | 8.8% |
NOVA PHARMACEUTICALS imports Paracetamol to 3 countries. The primary destination is AUSTRALIA receiving 80.8% of shipments worth $9.2M.
What Paracetamol Formulations Does NOVA PHARMACEUTICALS Import?
| Formulation | Value | Shipments |
|---|---|---|
| COLES CAPLETS - PARACETAMOL 500MG TABLET | $495.7K | 12 |
| COLES CAPLETS- PARACETAMOL 500MG TABLETS | $447.5K | 14 |
| HEDANOL- PARACETAMOL 500MG ROUND TABLETS | $387.5K | 10 |
| PARACETAMOL TAB BP 500MG RAPID RELEASE B | $380.0K | 25 |
| HEDANOL- PARACETAMOL 500MG TABLETS Pack. | $373.8K | 9 |
| PARACETAMOL TABLETS BP 500MG Batch No: 1 | $247.2K | 14 |
| PARACETAMOL TABLETS 500MG Batch No: 1301 | $244.1K | 6 |
| COLES CAPLETS PARACETAMOL 500MG TABLETSPack 2X10 S | $185.6K | 4 |
| PARACETAMOL AND CAFFEINE TAB 500/65 MG B | $176.4K | 13 |
| BLACK & GOLD PARACETAMOL 500MG TABLETS P | $169.8K | 8 |
NOVA PHARMACEUTICALS imports 314 distinct Paracetamol formulations from India. The top formulation is COLES CAPLETS - PARACETAMOL 500MG TABLET with 12 shipments worth $495.7K.
Regulatory Requirements: Importing Paracetamol into Australia
What NOVA PHARMACEUTICALS and other importers must comply with to import Paracetamol from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Paracetamol
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Paracetamol from India and How Much Does NOVA PHARMACEUTICALS Import?
India exported $71.5M worth of Paracetamol through 15,000 shipments from 870 suppliers to 170 countries, serving 2,197 buyers globally. NOVA PHARMACEUTICALS imports $11.4M of this total, accounting for 0.9% of India's Paracetamol exports with 553 shipments from AUSTRALIA. This is verified from 553 customs shipment records covering 314 distinct formulations.
What Is the Average Order Value for NOVA PHARMACEUTICALS's Paracetamol Imports?
NOVA PHARMACEUTICALS's average Paracetamol order value is $20.5K per consignment, based on 553 shipments totaling $11.4M. NOVA PHARMACEUTICALS is based in AUSTRALIA and ranks #12 among all Paracetamol importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Paracetamol to NOVA PHARMACEUTICALS?
NOVA PHARMACEUTICALS sources Paracetamol from 3 verified Indian suppliers: MARKSANS PHARMA LIMITED ($4.6M, 40.3%), V S INTERNATIONAL PRIVATE LIMITED ($4.1M, 35.8%), ADCOCK INGRAM LIMITED ($2.7M, 23.9%). This is based on 553 customs records.
How Does NOVA PHARMACEUTICALS Compare to Other Paracetamol Importers?
NOVA PHARMACEUTICALS ranks #12 among 2,197 Paracetamol importers from India with a 0.9% market share. The top 3 importers are ADCOCK INGRAM LIMITED. ($20.2M), ALLOGA UK AP7 ($9.6M), CENTRAFARM SERVICES B.V.(I) ($7.5M). NOVA PHARMACEUTICALS processed 553 shipments from AUSTRALIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paracetamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paracetamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NOVA PHARMACEUTICALS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NOVA PHARMACEUTICALS's capped import value divided by total capped export value for Paracetamol across all Indian exporters.
- 5.Verified Records: This page is backed by 553 individual customs records matching NOVA PHARMACEUTICALS importing Paracetamol, covering 314 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 170+ countries, 2,197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paracetamol Import Data for NOVA PHARMACEUTICALS
Access order-level details, pricing data, supplier connections, and competitive analysis for NOVA PHARMACEUTICALS's Paracetamol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NOVA PHARMACEUTICALS
Company Profile
Multiple products · $0 total trade · Multiple categories
NOVA PHARMACEUTICALS × Paracetamol
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NOVA PHARMACEUTICALS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paracetamol. For current order-level data, contact TransData Nexus.